Novartis receives EC approval for Enerzair® Breezhaler®, including the first digital companion (sensor and app) that can be prescribed alongside a treatment for uncontrolled asthma in the EU

NEXT STORY
Impact of COVID-19 on Europe’s Antibiotics Industry 2019-2027 by Drug Class, Mechanism of Action and Country
PREV STORY
The Global Biologics Market is expected to grow from USD 236,057.71 Million in 2019 to USD 304,866.47 Million by the end of 2025 at a Compound Annual Growth Rate (CAGR) of 4.35%
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

North American Partners in Anesthesia provides critical services to AdvantageCare Physicians patients in East New York, Brooklyn

author_avatar
NASDAQ Market News

Hemispherx Comments on $500+ Million Market Opportunity for Ampligen®, the Only Late Stage ME/CFS Candidate in the U.S.

ORLANDO, Fla., Jan. 23, 2018 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc. (NYSE American:HEB), focused ...

author_avatar
NASDAQ Market News

Ascendis Pharma A/S Announces First Quarter 2020 Financial Results and Business Update Conference Call on May 19

author_avatar
NASDAQ Market News